Term ends Apr 25, 2031 · High confidence
20-year base term ends Apr 25, 2031
Held by Zevra Therapeutics, Inc.
Filed Apr 25, 2011 as application 13/093,662 · Granted Nov 5, 2019
Base term plus 338 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2011
2031
Clock starts
Apr 25, 2011
Apr 25, 2011
Term ends
Apr 25, 2031
Apr 25, 2031
Granted
Nov 5, 2019
Nov 5, 2019
base term
fee events
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
338
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 9,511,037.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 338 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 2 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 25, 2011, when this application, 13/093,662, was filed | Apr 25, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +338 days, USPTO patent term adjustment record | Mar 28, 2032 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,511,037) | capped to Apr 25, 2031 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 25, 2031 | High confidence |
This family
| US 10,463,633 | this patent Apr 2031 | Apr 2031 |
| US 9,511,037 | In force Apr 2031 | Apr 2031 |
| US 10,912,744 | In force Apr 2031 | Apr 2031 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 20, 2012 Reel 28815, frame 281 | Desai, Subhash | Genco Sciences LLC | Assignment of Assignor's Interest |
| Oct 10, 2017 Reel 43824, frame 734 | Genco Sciences LLC | Kempharm, Inc. | Assignment of Assignor's Interest |
| Feb 23, 2024 Reel 66664, frame 108 | Kempharm, Inc. | Zevra Therapeutics, Inc. | Change of Name |
| Apr 8, 2024 Reel 67040, frame 637 | Zevra Therapeutics, Inc. | Alter Domus (US) LLC | Security Interest |
| Mar 13, 2026 Reel 75080, frame 907 | Alter Domus (US) LLC | Zevra Therapeutics, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Apr 2031
Term ends Apr 25, 2031. Maintenance fees still fall due before then
Note
The 338 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 9,511,037.
Citations
49
later US patents cite this one
That is top 5% of utility patents granted in 2019 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.